Finally, a recent study in NAFLD patients observed a lack of correlation between serum liver enzymes including ALT and changes in steatosis, inflammation, hepatocyte ballooning, or fibrosis stage over time [38]. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.